Important points in management of patients with choroidal neovascularization.
The efficacy of argon blue-green laser treatment for extrafoveal choroidal neovascularization (CNV) in aging macular degeneration, presumed ocular histoplasmosis syndrome and idiopathic choroidal neovascularization has recently been proven by the Macular Photocoagulation Study. These results are applicable only to eyes managed according to certain principles of therapy and post-treatment follow-up. These include the use of a recent fluorescein angiogram and retrobulbar anesthetic, aiming for complete obliteration of the CNV. Meticulous post-treatment follow-up is critical. This includes daily patient monitoring of the Amsler grid, and prompt examinations if distortion is noted. Excellent quality fluorescein angiography is mandatory. This is repeated frequently and studied promptly. Residual or recurrent extrafoveal CNV requires prompt re-treatment.
L J
LJ
Singerman
D002829:Choroid / Q000098:blood supply*; D005451:Fluorescein Angiography; D006801:Humans; D053685:Laser Therapy; D007834:Lasers; D008268:Macular Degeneration / Q000175:diagnosis / Q000601:surgery; D009389:Neovascularization, Pathologic / Q000175:diagnosis / Q000601:surgery*; D012008:Recurrence